SS-31 vs FLGR-242: Mechanism, Half-Life & Research Use
Evaluating mitochondrial-targeted peptides alongside growth factor signaling modulators requires a precise understanding of their distinct molecular targets. SS-31 selectively interacts with cardiolipin in the inner mitochondrial membrane to preserve bioenergetic efficiency, whereas FLGR-242 acts within growth factor pathways to influence cellular differentiation and tissue remodeling. This technical guide outlines the comparative mechanisms, half-lives, and experimental considerations for lab protocols.
Quick answer
Evaluating mitochondrial-targeted peptides alongside growth factor signaling modulators requires a precise understanding of their distinct molecular targets. SS-31 selectively interacts with cardiolipin in the inner mitochondrial membrane to preserve bioenergetic efficiency, whereas FLGR-242 acts within growth factor pathways to influence cellular differentiation and tissue remodeling. This technical guide outlines the comparative mechanisms, half-lives, and experimental considerations for lab protocols.
Key takeaways
- [SS-31](/research-peptides/ss-31) (Elamipretide) is a synthetic tetrapeptide designed to selectively target cardiolipin within the inner mitochondrial membrane, optimizing electron transport chain activity and suppressing excess reactive oxygen species (ROS) production.
- To streamline assay planning, the following table summarizes the core chemical, physical, and mechanistic properties of [SS-31](/research-peptides/ss-31) and FLGR-242 based on preclinical literature and laboratory specifications.
- [SS-31](/research-peptides/ss-31), chemically known as D-Arg-2',6'-Dmt-Lys-Phe-NH2, possesses an alternating aromatic-cationic motif that allows it to freely penetrate cell membranes and enrich within the inner mitochondrial membrane (IMM).
- FLGR-242 is a bioengineered peptide fragment derived to interact with regulatory proteins within the Transforming Growth Factor-beta (TGF-beta) superfamily, including myostatin (GDF-8) and activin pathways.
SS-31 vs FLGR-242: High-Level Comparative Overview
SS-31 (Elamipretide) is a synthetic tetrapeptide designed to selectively target cardiolipin within the inner mitochondrial membrane, optimizing electron transport chain activity and suppressing excess reactive oxygen species (ROS) production. In contrast, FLGR-242 is a specialized peptide fragment engineered to modulate growth factor signaling pathways, primarily influencing cellular proliferation, extracellular matrix dynamics, and tissue differentiation. They represent two entirely distinct mechanistic classes for laboratory investigation.
When designing in vitro or animal studies, choosing between these compounds depends on the primary physiological system under evaluation. Researchers investigating bioenergetics, mitochondrial decay, or ischemia-reperfusion models generally select SS-31. Conversely, research models focused on musculoskeletal regeneration, TGF-beta pathway inhibition, or cell proliferation pathways prioritize FLGR-242. Both compounds are available across our complete catalog of research peptides for qualified laboratory facilities.
Head-to-Head Comparison Matrix
To streamline assay planning, the following table summarizes the core chemical, physical, and mechanistic properties of SS-31 and FLGR-242 based on preclinical literature and laboratory specifications.
| Criteria | SS-31 (Elamipretide) | FLGR-242 | | :--- | :--- | :--- | | **Primary Receptor / Target** | Inner mitochondrial membrane cardiolipin | Growth factor / TGF-beta signaling complex | | **Mechanistic Class** | Mitochondrial targeted antioxidant / Bioenergetic stabilizer | Growth factor signaling modulator | | **Reported Half-Life (In Vivo / Plasma)** | ~2 to 4 hours (plasma); extended tissue retention | ~1 to 3 hours (plasma in rodent models) | | **Solubility Profile** | High solubility in sterile water / PBS (pH 7.4) | Soluble in dilute acetic acid / DMSO, then buffered PBS | | **Typical Preclinical Model** | Ischemia-reperfusion, oxidative stress assays, heart failure models | Muscle wasting assays, fibrosis models, cell culture expansion | | **Available Lab Vial Sizes** | 10mg, 50mg lyophilized powder | 2mg, 5mg, 10mg lyophilized powder |
Molecular Mechanism of SS-31 (Elamipretide)
SS-31, chemically known as D-Arg-2',6'-Dmt-Lys-Phe-NH2, possesses an alternating aromatic-cationic motif that allows it to freely penetrate cell membranes and enrich within the inner mitochondrial membrane (IMM). Preclinical studies suggest that its primary mechanism involves electrostatic and hydrophobic interactions with cardiolipin, an essential phospholipid exclusive to the IMM.
By binding cardiolipin, SS-31 prevents its peroxidation by cytochrome c, stabilizing the structural architecture of the mitochondrial cristae. In vitro assays demonstrate that this structural stabilization optimizes electron flow through Complexes I–IV, maintains ATP synthesis rates, and prevents electron leakage that would otherwise generate damaging superoxide radicals. Crucially, SS-31 exhibits this antioxidant capacity without depleting physiological signaling levels of ROS.
Molecular Mechanism of FLGR-242
FLGR-242 is a bioengineered peptide fragment derived to interact with regulatory proteins within the Transforming Growth Factor-beta (TGF-beta) superfamily, including myostatin (GDF-8) and activin pathways. Unlike broad-spectrum inhibitors, FLGR-242 is designed to specifically block the interaction between negative growth regulatory ligands and their surface receptors.
In cell culture models, application of FLGR-242 has been shown to downregulate Smad2/3 phosphorylation cascades, thereby altering nuclear transcription factors associated with muscle protein degradation and fibrotic tissue deposition. This molecular targeting allows investigators to explore muscle mass preservation, extracellular matrix turnover, and anti-fibrotic signaling in controlled experimental setups.
Preclinical Evidence Base for SS-31
The literature surrounding SS-31 is extensive across multiple preclinical animal models. In rodent models of renal ischemia-reperfusion injury, administration of SS-31 prior to or during reperfusion preserved mitochondrial ultrastructure, reduced tubular cell apoptosis, and significantly suppressed proinflammatory cytokine release.
Additional preclinical data in age-accelerated murine models indicate that SS-31 administration restores mitochondrial coupling efficiency in skeletal and cardiac muscle, leading to improved endurance and reduced baseline fatigue parameters. These findings highlight SS-31 as a gold-standard reference compound for investigations centered on mitochondrial quality control, cardiolipin dynamics, and age-related metabolic dysfunction.
Preclinical Evidence Base for FLGR-242
FLGR-242 has gathered attention primarily within musculoskeletal and regenerative biology literature. In rodent models of immobilization-induced muscle atrophy, treatment with FLGR-242 significantly attenuated cross-sectional area loss in muscle fibers by suppressing ubiquitin-proteasome system activation.
Furthermore, in vitro fibroblast assays reveal that FLGR-242 suppresses excessive collagen type I and III deposition induced by exogenous TGF-beta 1. These results suggest that FLGR-242 holds utility not only in muscle regeneration models but also in organ fibrosis research, where extracellular matrix remodeling must be finely regulated.
Pharmacokinetics, Half-Life, and Stability Profiles
Understanding pharmacokinetic profiles is essential for establishing dosing schedules in preclinical trial designs. SS-31 exhibits a short systemic plasma half-life of approximately 2 to 4 hours in rodent species; however, due to its high affinity for cardiolipin, tissue retention within the heart, kidneys, and skeletal muscle extends far beyond its plasma presence.
FLGR-242 displays a plasma half-life estimated at 1 to 3 hours in murine models. Because it acts on extracellular receptor complexes and circulating growth factors, maintaining constant local concentration via osmotic mini-pumps or repeated daily dosing protocols is frequently required in animal studies. Both peptides exhibit high stability in lyophilized form when stored at -20°C, but require careful handling once reconstituted in liquid media.
Protocol Selection: Matching Peptides to Experimental Design
Selecting between SS-31 and FLGR-242 depends entirely on the biological primary endpoint of your protocol. If your laboratory study aims to measure cellular respiration, mitochondrial membrane potential (Delta Psi m), oxygen consumption rate (OCR), or ROS generation, SS-31 is the appropriate research compound.
If your experimental parameters involve myoblast differentiation, satellite cell activation, inhibition of fibrotic markers (e.g., Alpha-SMA), or myostatin blockade, FLGR-242 provides the direct target interaction required. Researchers investigating systemic metabolic decline occasionally explore comparative trials incorporating both compounds across distinct experimental arms to delineate mitochondrial energy production from structural tissue maintenance.
Cross-Class Comparative Context: Related Compounds
To build robust topical models, laboratories frequently compare SS-31 and FLGR-242 against other specialized compounds in the metabolic and tissue regeneration classes. For instance, mitochondrial research protocols often contrast SS-31 with the mitochondrial-derived peptide MOTS-c, which regulates nuclear gene expression involved in metabolic homeostasis through AMPK activation rather than direct cardiolipin binding.
Similarly, within growth factor and tissue remodeling models, researchers compare FLGR-242 with broader systemic inhibitors such as Follistatin-315 or cytoprotective repair peptides like BPC-157. Evaluating these parallel compounds allows researchers to map out distinct signal transduction pathways in both cellular assays and in vivo models.
Laboratory Reconstitution, Buffer Compatibility, and Storage Protocols
Proper reconstitution is vital to maintaining peptide integrity and preventing batch degradation. SS-31 is highly hydrophilic and dissolves rapidly in sterile bacteriostatic water or standard phosphate-buffered saline (PBS, pH 7.4) up to concentrations of 20 mg/mL. For accurate volumetric measurements in benchwork, researchers should utilize our reconstitution calculator.
FLGR-242, depending on its specific sequence modification, may require initial solubilization in a small volume of 0.1% dilute acetic acid or sterile DMSO before diluting into final culture media or PBS. Avoid vigorous vortexing or rapid agitation for both peptides; gentle inversion is recommended to avoid shear stress on peptide bonds. Reconstituted aliquots should be frozen at -80°C to prevent repeated freeze-thaw cycles.
PX1 Research Quality Protocols: Analytical Rigor and COAs
At PX1 Research, every batch of SS-31 and FLGR-242 is synthesized in state-of-the-art, GMP-compliant facilities within the USA. We enforce rigid quality control standards to ensure that experimental results remain highly reproducible across research trials.
Every production lot undergoes rigorous High-Performance Liquid Chromatography (HPLC) to verify chemical purity (exceeding 98%) and Mass Spectrometry (MS) to confirm molecular weight accuracy. Furthermore, all products are endotoxin-tested (<0.01 EU/mg) in an ISO 17025 accredited laboratory. Researchers can review and download lot-specific documentation directly via our COA database. For bulk inquiries or custom lab allocations, visit our wholesale portal or explore our broader research library.
Frequently Asked Questions
What is the key functional difference between SS-31 and FLGR-242?
SS-31 is a mitochondrial-targeted tetrapeptide that selectively binds cardiolipin to reduce ROS and optimize ATP production. FLGR-242 is a growth factor signaling peptide designed to modulate extracellular tissue growth and TGF-beta signaling pathways.
Are SS-31 and FLGR-242 intended for human or veterinary use?
No. Both SS-31 and FLGR-242 are strictly supplied as research-grade compounds for in vitro assays and laboratory animal research only. They are never for human, clinical, or veterinary administration.
How should lyophilized SS-31 and FLGR-242 be stored upon arrival?
Lyophilized vials should be stored at -20°C or -80°C in a dry environment away from light. Under these conditions, the compounds remain stable for up to 24 months.
What solvents are recommended for reconstituting FLGR-242?
FLGR-242 may require initial solubilization in sterile 0.1% dilute acetic acid or a low concentration of DMSO prior to dilution in sterile phosphate-buffered saline (PBS, pH 7.4).
What purity levels are guaranteed for PX1 Research peptides?
All peptides supplied by PX1 Research undergo rigorous HPLC and MS testing, guaranteeing a minimum of 98% chemical purity with lot-specific Certificates of Analysis available online.
What are the reported endotoxin limits for these research compounds?
PX1 Research enforces strict quality protocols, ensuring endotoxin levels remain below 0.01 EU/mg, preventing confounding inflammatory responses in cell culture and animal models.
Can SS-31 and FLGR-242 be used together in the same experimental model?
Yes, in preclinical research designs evaluating combined mitochondrial stabilization and growth pathway modulation, researchers may administer both compounds in separate experimental arms or co-treat cultures.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based GMP-compliant facilities and shipped directly from our distribution centers in California and Arizona with same-day dispatch for orders placed Monday through Friday.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.